Shale, shale, and more shale.
That’s been the story behind our oil and gas boom for the past five years. And if we include the steady, long-term decline in conventional production, shale plays have been the only story worth following for investors.
Our natural gas industry has had eerily similar experiences. Earlier this week, I mentioned how the flood of shale gas is the reason natural gas producers have been so successful (the EIA’s production data supports as much).
But it’s not enough to simply recognize that natural gas prices are making a comeback, or that major players like ExxonMobil are paying a hefty price for their own piece of the shale profits…
For individual investors, knowing the difference between the various shale formations is critical when separating the good, the bad, and the downright profitable.
The Good, the Bad, and the Downright Profitable
Where to begin?
We can pinpoint the start of the shale boom with a technological breakthrough George Mitchell used to tap the Barnett shale play back in the 1980s…
The Barnett Shale
The formation lies beneath nearly two dozen Texas counties, spanning roughly 5,000 square miles.
In case you were wondering, this is what started it all…
In short order, the Barnett became the largest onshore natural gas field in the U.S., with an estimated 40 trillion cubic feet in the ground. For the last twenty years, the formation has produced more than 12 trillion cubic feet of natural gas, and today there are over 16,000 gas wells on record in the Barnett.
However, low-price natural gas environment has taken its toll. Below you can see how production declined in 2012 for the first time since 1993, as did the number of drilling permits issued throughout the year (click to enlarge):
Despite hitting new production highs in 2011, the Barnett’s success led a rush for companies to develop new shale plays across the lower 48 states — including a shale play sitting over 200 miles directly east of Fort Worth…
The Haynesville Shale
Consisting mostly of sedimentary rock, the Haynesville Shale play is found roughly 10,000 feet below parts of northwestern Louisiana, Arkansas, and Texas’ eastern border.
If you had a dime in shale investments back in 2008, you would have made a solid profit on companies drilling in the play. The buzz over the Haynesville rose at a feverish pace.
Output quickly skyrocketed as drillers frantically tried to extract the 60 trillion cubic feet held tightly within the rock… and they were extremely successful.
According to data from the Energy Information Administration, the Haynesville overtook the Barnett as the country’s highest-producing shale gas deposit back in March 2011:
Unfortunately, 2013 is shaping up to be a frustrating year for Haynesville operators. It’s next to impossible for output to increase after watching drilling activity diminish over the last year.
In the wake of sub-$4 natural gas and crude oil holding steady around $90 per barrel, companies are moving to more liquids-rich targets like the Eagle Ford play in South Texas.
Is that it for the shale gas boom?
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
The Marcellus Formation
We’ve been talking about one formation in particular that has the legs to last.
Even though prices are cheap, the Marcellus Shale is still one of the hottest unconventional plays in the U.S. — and that’s taking into account the drastic cut in estimated reserves from the EIA.
Back in 2011, the EIA reported the Marcellus held 141 trillion cubic feet of natural gas (slightly higher than the USGS estimate of 84 trillion cubic feet).
This formation stretches across five states, from New York to West Virginia, with the vast majority in Pennsylvania.
Between Pennsylvania and West Virginia, companies produce about 7 billion cubic feet of natural gas per day. At this rate, Marcellus production from these two states is roughly one-quarter of our U.S. shale gas production — and has more than doubled since 2011.
Although drilling activity is also at a two-year low, that won’t deter some of the bigger players from spending cash developing their Marcellus assets…
CONSOL Energy is directing two-thirds of its 2013 spending on coal and gas investments on its Marcellus operations.
A 2012 report from Standard & Poor suggested the Marcellus Formation held nearly half of the proven natural gas reserves in the United States.
The Tools to Profit
So, what do we do?
Easy: We stick with the what works.
In this case, it’s finding the right shale play at the right time — at least, that’s what some of the wealthiest investors are doing.
That much should have been obvious when billionaire investor Carl Icahn took an 8.9% stake in Chesapeake Energy, making him the second-largest shareholder at a cost of $951 million.
Still, his nearly $1 billion investment in Chesapeake is dwarfed by Warren Buffett’s $34 billion shale bet…
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.